In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called "hot" tumors with increased levels of inflammation and the presence of immune cells in and around the tumors. Prostate ...
Jun 24, 2021
0
4
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used against them.
Jun 18, 2021
0
16
Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumors have faulty copies of the BRCA cancer genes.
Jun 17, 2021
0
24
Oncotarget published "The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia" reported that polymorphisms ...
Jun 11, 2021
0
2
Prostate cancer is the second most common cancer among men, according to the American Cancer Society. It's also one of the trickiest cancers to diagnose and treat.
Jun 10, 2021
0
22
The University of Delaware's Aditya Dutta and collaborators are investigating the NKX3.1 gene and its role in prostate cancer—the most common cancer and the second-leading cause of cancer-related death among men in the ...
Jun 7, 2021
0
6
Doctors are reporting improved survival in men with advanced prostate cancer from an experimental drug that delivers radiation directly to tumor cells.
Jun 3, 2021
1
23
According to new findings published in Science Translational Medicine, Cleveland Clinic researchers have identified a promising drug target for treating and preventing aggressive, drug-resistant prostate cancer.
May 26, 2021
0
19
Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells—and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast ...
May 19, 2021
0
38
Targeting a molecule on the surface of immune cells could offer an exciting new way to treat prostate cancer by reawakening the immune response against it.
May 10, 2021
0
3
